Table 10.
Distribution of other concomitant drugs reported with aripiprazole and risperidone belonging to the Anatomical Therapeutic Chemical (ATC) N group third level: drugs acting on nervous system.
| Concomitant drug | ARI | RIS | p |
|---|---|---|---|
| Antidepressants | 116 (25.6) | 86 (15.9) | <0.05 |
| Psychostimulants, agents used for ADHD And nootropics | 87 (19.2) | 108 (19.9) | >0.05 |
| Antipsychotics | 79 (17.4) | 105 (19.4) | >0.05 |
| Antiepileptics | 70 (15.4) | 96 (17.7) | >0.05 |
| Anxiolytics | 46 (7.9) | 53 (9.8) | >0.05 |
| Hypnotics and sedatives | 30 (6.6) | 39 (7.2) | >0.05 |
| Anticholinergic agents | 18 (4.0) | 20 (3.7) | >0.05 |
| Analgesic | 6 (1.3) | 12 (2.2) | >0.05 |
| Drugs used in addictive disorders | 2 (0.4) | 1 (0.2) | <0.05 |
| Anti-parkinson | – | 3 (0.6) | – |
| General anesthetics | – | 4 (0.7) | – |
| Anti-migrane | – | 14 (2.6) | – |
| Local anesthetics | – | 1 (0.2) | – |
| Total | 454 (100) | 542 (100) |
ARI, aripiprazole; RIS, risperidone; ADHD, attention-deficit/hyperactivity disorder.